SCHEMBL5579362

SCHEMBL5579362

O=C(NO)c1ccc2c(c1)NC(=O)C(Cc1c[nH]c3ccccc13)NC2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.52
HDAC6 Q9UBN7 4/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
GSK3B P49841 2/20 0.48
HDAC2 Q92769 2/20 0.48
RAB9A P51151 1/20 0.43
LMNA P02545 1/20 0.43
PKM P14618 1/20 0.43
CCKBR P32239 3/20 0.42
HDAC3 O15379 1/20 0.42
KDM1A O60341 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082222 1.00 IDO1 (0.52) IDO1HDAC6HDAC8HDAC1HDAC4
SCHEMBL5078957 1.00 IDO1 (0.52) IDO1HDAC6HDAC8HDAC1HDAC4
SCHEMBL5082100 0.89 IDO1 (0.55) IDO1HDAC6HDAC8HDAC1HDAC4
SCHEMBL5079028 0.89 IDO1 (0.55) IDO1HDAC6HDAC8HDAC1HDAC4
Benzodiazepinedione SCHEMBL10968598 0.81 IDO1 (0.65) IDO1GSK3BCCKBRMEN1KMT2A
Benzodiazepinedione SCHEMBL29799531 0.81 IDO1 (0.65) IDO1GSK3BCCKBRMEN1KMT2A
Benzodiazepinedione SCHEMBL10832629 0.81 IDO1 (0.65) IDO1GSK3BCCKBRMEN1KMT2A
SCHEMBL5579378 0.76 HDAC3 (0.53) IDO1HDAC6HDAC8HDAC1GSK3B
SCHEMBL5579382 0.76 HDAC3 (0.53) IDO1HDAC6HDAC8HDAC1GSK3B
SCHEMBL5081684 0.74 GAA (0.54) HDAC6HDAC8HDAC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase METHYLGENE, INC. (CA) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase HDAC5, HDAC4, HDAC3 IDO1 1753/4885HDAC6 24/4885HDAC8 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.